Medy-Tox Inc. (KOSDAQ:086900)
South Korea
· Delayed Price · Currency is KRW 164,700
-8,000 (-4.63%)
Jun 5, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Biopharmaceutical Products | 217.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopharmaceutical Products Growth | 13.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Other | 226.72M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 79.82B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 19.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 73.71B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | 6.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| America | 48.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| America Growth | 10.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Middle East | 8.54B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Middle East Growth | 73.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 6.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 0.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 226.72M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oceania | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oceania Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|